Kolon Life Science Inc. (KOSDAQ:102940)
South Korea · Delayed Price · Currency is KRW 14,560
-140 (-0.95%)
Sep 3, 2026, 3:30 PM KST
Kolon Life Science Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 30,696 | 10,636 | 12,498 | 7,561 | 6,371 | 27,800 |
Short-Term Investments | 1,000 | - | - | - | - | 110 |
Cash & Short-Term Investments | 31,696 | 10,636 | 12,498 | 7,561 | 6,371 | 27,910 |
Cash Growth | 80.09% | -14.90% | 65.29% | 18.68% | -77.17% | 85.69% |
Accounts Receivable | 43,014 | 37,205 | 36,699 | 24,605 | 29,440 | 19,649 |
Other Receivables | 372.77 | 216.61 | 1,094 | 1,008 | 302.04 | 638.16 |
Receivables | 43,387 | 37,421 | 37,794 | 25,613 | 29,742 | 20,287 |
Inventory | 75,151 | 56,236 | 46,726 | 67,777 | 68,494 | 45,998 |
Prepaid Expenses | 5,654 | 3,335 | 4,127 | 3,406 | 4,579 | 3,743 |
Other Current Assets | 748.04 | 406.65 | 909.02 | 688.31 | 998.16 | 82.57 |
Total Current Assets | 156,635 | 108,035 | 102,055 | 105,045 | 110,184 | 98,021 |
Property, Plant & Equipment | 135,875 | 132,183 | 115,076 | 123,138 | 125,960 | 131,481 |
Long-Term Investments | 785,849 | 668,317 | 197,223 | 77,054 | 75,240 | 2,549 |
Goodwill | - | - | - | - | 1,217 | 1,217 |
Other Intangible Assets | 1,100 | 1,027 | 554.34 | 168.28 | 58.95 | 99.11 |
Long-Term Accounts Receivable | 0 | 0 | -0 | 0 | -0 | -0 |
Long-Term Deferred Charges | - | 1.5 | 44.86 | 164.25 | 283.64 | 403.04 |
Other Long-Term Assets | 4,614 | 4,850 | 4,610 | 3,866 | 1,174 | 888.54 |
Total Assets | 1,084,073 | 914,413 | 419,563 | 309,436 | 314,118 | 234,658 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 14,668 | 12,930 | 11,950 | 7,442 | 17,049 | 13,774 |
Accrued Expenses | 4,365 | 5,057 | 4,908 | 4,355 | 3,594 | 3,145 |
Short-Term Debt | 155,305 | 92,155 | 105,890 | 97,262 | 69,461 | 59,064 |
Current Portion of Long-Term Debt | - | 4,996 | 9,993 | - | 4,000 | 5,333 |
Current Portion of Leases | 873.79 | 628.43 | 692.76 | 428.66 | 287.62 | 336.45 |
Current Income Taxes Payable | 92.16 | 599.13 | - | - | 376.36 | - |
Current Unearned Revenue | 3,201 | 3,201 | 3,201 | 3,201 | 3,201 | 3,500 |
Other Current Liabilities | 28,707 | 50,216 | 69,620 | 15,653 | 11,608 | 10,316 |
Total Current Liabilities | 207,212 | 169,783 | 206,255 | 128,341 | 109,578 | 95,469 |
Long-Term Debt | - | 4,990 | 8,699 | 9,980 | - | 4,000 |
Long-Term Leases | 1,155 | 960.43 | 1,324 | 191.33 | 167.18 | 191.02 |
Pension & Post-Retirement Benefits | 2,640 | 3,498 | 6,831 | 6,439 | 9,812 | 10,449 |
Long-Term Deferred Tax Liabilities | 164,779 | 138,954 | 33,629 | 9,874 | 9,760 | - |
Other Long-Term Liabilities | 11,361 | 12,196 | 13,487 | 16,938 | 17,078 | 25,139 |
Total Liabilities | 387,147 | 330,382 | 270,225 | 171,764 | 146,395 | 135,248 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 6,545 | 6,454 | 6,212 | 5,706 | 5,706 | 5,706 |
Additional Paid-In Capital | 211,010 | 208,233 | 192,801 | 167,553 | 209,114 | 209,542 |
Retained Earnings | -185,030 | -203,380 | -228,091 | -133,289 | -101,537 | -106,024 |
Treasury Stock | - | - | - | - | - | -812.88 |
Comprehensive Income & Other | 664,399 | 572,724 | 178,417 | 97,702 | 54,440 | -9,001 |
Shareholders' Equity | 696,926 | 584,030 | 149,338 | 137,672 | 167,723 | 99,410 |
Total Liabilities & Equity | 1,084,073 | 914,413 | 419,563 | 309,436 | 314,118 | 234,658 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 157,334 | 103,730 | 126,598 | 107,863 | 73,916 | 68,925 |
Net Cash (Debt) | -125,638 | -93,094 | -114,100 | -100,301 | -67,545 | -41,015 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -8432.05 | -6496.63 | -9553.48 | -8788.83 | -5344.94 | -3597.74 |
Filing Date Shares Outstanding | 13.09 | 12.91 | 12.42 | 11.41 | 11.41 | 11.4 |
Total Common Shares Outstanding | 13.09 | 12.91 | 12.42 | 11.41 | 11.41 | 11.4 |
Working Capital | -50,577 | -61,748 | -104,200 | -23,296 | 606.75 | 2,552 |
Book Value Per Share | 53250.43 | 45248.71 | 12020.68 | 12063.41 | 14696.64 | 8720.06 |
Tangible Book Value | 695,825 | 583,003 | 148,783 | 137,504 | 166,448 | 98,094 |
Tangible Book Value Per Share | 53166.37 | 45169.14 | 11976.05 | 12048.67 | 14584.86 | 8604.64 |
Land | 16,316 | 16,316 | 16,281 | 16,281 | 17,286 | 17,008 |
Buildings | 63,260 | 86,468 | 81,462 | 88,069 | 88,567 | 88,891 |
Machinery | 35,003 | 123,620 | 108,063 | 104,638 | 101,589 | 102,952 |
Construction In Progress | 19,254 | 18,056 | 13,857 | 17,810 | 16,474 | 15,952 |